Park Hyatt Aviara
7100 Aviara Resort Drive
Carlsbad, CA 92011
The Cell & Gene Meeting on the Mesa is the sector’s one of the foremost annual conferences bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 80+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
Mission Bio is committed to being your trusted partner to help tackle the commercialization challenges facing the industry today and accelerate your therapy development programs. As a Gold Sponsor of the 2021 Cell & Gene Meeting on the Mesa, we are excited to meet fellow scientists and industry experts to discuss how we can enable our customers’ success.
Mission Bio’s CEO, Yan Zhang, Ph.D., will be presenting in person on October 13th at 4:30 p.m. to discuss our mission – deepening your understanding of the heterogeneity in CGTs so you can develop safe and efficacious treatments that improve patients’ lives. Come learn more about how we can be your strategic partner for customized, scalable assay development, from early discovery through IND-enabling studies and beyond.
Date: Wednesday, October 13, 4:30 p.m. PST
Location: AVROBIO Ballroom at Park Hyatt Aviara
Please reach out before or during the event to set up a meeting with our team of cell and gene therapy experts on-site and learn about implementing single-cell analysis in advanced therapy development and our Pharma Assay Development (PAD) services.
